In Uganda, a tougher bicycle offers hope for better health coverage in rural areas
LIRA, Uganda (AP) — The bicycle parked in Lucy Abalo's compound doesn't belong to her. Any one of the hundreds of people in her village can show up and ask to use it.
A man might wish to take his pregnant wife for a checkup. A woman might need transport to pick up HIV medication. An injured child might need a trip to a hospital.
'The goodness about this bike,' Abalo said, is its availability to all.
She is one of dozens of 'village doctors' in rural Uganda who recently were supplied with the Buffalo Bicycle, so called because its steel parts are reinforced to perform in areas with bad roads.
World Bicycle Relief, a Chicago-based nonprofit, promotes the Buffalo Bicycle in remote parts of Africa. It collaborates with governments, non-governmental groups and others who use the bikes to improve access to health services.
In Uganda, an east African country of 45 million people, efforts to market the bicycle have focused on supporting health workers like Abalo, who visits people's homes and reports any issues to authorities.
As a community health extension worker, or CHEW, she has gained the trust of villagers, who can knock on her door in emergency situations. She said she helps to look after about 8,000 people in the area.
And at least twice a week, she is required to report to a government-run health center about 5 kilometers (3 miles) away and assist with triaging patients.
Ugandan health authorities acknowledge that one challenge for CHEWs is transportation, part of a larger burden of poverty that can leave health facilities lacking ambulances or even gas to move them.
World Bicycle Relief, operating locally as Buffalo Bicycles Uganda, has collaborated with Ugandan health authorities since 2023 to equip 331 CHEWs in two of the country's 146 districts. One is Lira, 442 kilometers (274 miles) north of the capital, Kampala.
Bicycles have long been ubiquitous, and many families tend to have one. Cultural norms in northern Uganda don't prohibit women from riding. While the roads in Lira town are paved, dirt paths lead into the heart of the district where farming is the main economic activity.
The Buffalo Bicycle is a recent arrival. Many have never heard of it, or can't afford it. Retailing for roughly $200, it is three times more expensive than the cheapest regular bicycle — otherwise out of reach for many CHEWs, who do not yet earn a salary.
The bike's promoters cite its durability in rough terrain, needing fewer trips to the mechanic as a way to save money.
The Buffalo Bicycle's heavy-gauge steel frame is so strong that it comes with a five-year warranty, said Amuza Ali, a monitoring officer in Lira for Buffalo Bicycles Uganda.
Abalo and others told the AP the Buffalo Bicycle felt uncomfortable to use in the beginning, with a braking system that doesn't permit carefree backpedaling.
'When I climbed on it, it wasn't that easy as I thought,' Abalo said. 'I was like, 'I am trying again to learn how to ride.''
CHEWs using the bicycles reported a 108% increase in households reached each week, and the time to reach health facilities dropped by nearly half, according to a study published in May by World Bicycle Relief.
The study shows that 'mobility is not a luxury in healthcare' but a lifeline, CEO Dave Neiswander said in a statement released for the report.
Diana Atwine, permanent secretary at the Ministry of Health, has urged the distribution of bicycles to more CHEWs across Uganda, saying front-line health workers save an unknown number of lives each year.
Abalo received her Buffalo Bicycle from the health minister last year.
One of her neighbors, Babra Akello, said she has used the bicycle at least six times already. The first was for transport to an antenatal checkup. She praised Abalo's willingness to help.
The bike has also been used for emergencies. One evening earlier this year, a neighbor's 4-year-old child suffered a deep cut while playing in the dirt. With the child's parents away, Abalo transported the bleeding boy to a facility where he briefly lost consciousness before being revived.
'That bike, not me, saved the life of that child,' Abalo said. 'If that bike hadn't been there, I don't know what would have happened.'
___
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
31 minutes ago
- Hamilton Spectator
Health officials issue warnings as UK bakes in the first heat wave of 2025
LONDON (AP) — British health officials are warning people across the country to take precautions when out in the sun as the U.K. bakes under its first heat wave of the year. Temperatures are expected to peak at 34 degrees Celsius (93 degrees Fahrenheit) in some parts of eastern England on Saturday following a week of unusually warm weather, according to the national weather agency the Met Office. That's about 12 C (22 F) higher than normal for this time of year. The U.K. Health Security Agency has issued an amber heat health alert covering all of England because of increased health risks for people over 65 and those with heart and lung problems. 'Heat can result in serious health outcomes across the population, especially for older adults or those with pre-existing health conditions,' Dr. Agostinho Sousa, head of the UKHSA, said in a statement. 'It is therefore important to check on friends, family and neighbors who are more vulnerable and to take sensible precautions while enjoying the sun.' Saturday is expected to be the hottest day of the heat wave, with temperatures falling slightly on Sunday and dropping back into the more normal temperatures next week, the Met Office said. The heat alert is currently scheduled to remain in effect until Monday morning. Unusually, temperatures in London this week have been higher than in many parts of Western Europe. That's because the high temperatures are not the result of hot air moving north from the Iberian Peninsula or North Africa as is often the case, the Met Office said. Instead, this weather system originated in air high over the Atlantic Ocean south of Greenland. As it approaches the U.K., it descends toward ground level, causing it to warm rapidly, Chief Meteorologist Matthew Lenhert said. That said, it has been plenty hot in Europe too. Aviation enthusiasts attending the Paris Air Show in Le Bourget, north of Paris, this week sought the shade of a Boeing 777's wing, cooling off as temperatures hovered in the low 30s C (mid-80s F.) Met Office scientists this week published research showing that climate change is increasing the likelihood of extreme high temperatures in the U.K. The chance of temperatures exceeding 40 Celsius (104 F) is now more than 20 times higher than it was in the 1960s, the researchers said.
WIRED
an hour ago
- WIRED
The FDA Just Approved a Long-Lasting Injection to Prevent HIV
Jun 20, 2025 7:30 AM Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug's affordability. Photograph: Konstantin Voronov/GETTY IMAGES The US Food and Drug Administration has just approved lenacapavir, an injectable form of HIV prevention that is almost 100 percent effective and requires only two doses per year. Science magazine described the medicine the most important scientific advance of 2024. In clinical trials, lenacapavir proved to be 99.9 percent effective in preventing HIV infection through sexual transmission in people weighing more than 35 kilograms. The drug, an antiretroviral, works not by stimulating an immune response, but by blocking HIV from reproducing during its early stages—specifically, by disrupting the function of the virus's capsid protein. This happens so long as the body receives injections every six months. Lenacapavir has already been approved in some countries as a treatment for HIV in people with forms of the virus that are resistant to other treatments. However, prior to this week, its prophylactic use had not been approved anywhere, making the FDA's decision a significant new development in the fight against the HIV/AIDS epidemic. The drug is not the first medicine that can be taken preemptively to protect against an HIV infection: pre-exposure prophylaxis (PrEP) pills were already available in many countries, including the United States. But these must be taken every day, and ensuring ongoing access to these medicines, and that people actually remember to take them, is a known challenge. It's hoped the long-lasting effects of lenacapavir will make it easier for people to stay protected against the virus. According to its creator, Gilead Sciences, lenacapavir will be marketed under the trade name Yeztugo. The company has committed to manufacturing 10 million doses by 2026. 'This is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic,' Daniel O'Day, president and CEO of Gilead, said in a statement on Wednesday. However, lenacapavir's price may be a barrier to access. Yeztugo will have an annual list price of $28,218 per person in the US. Winnie Byanyima, executive director of of the Joint United Nations Program on HIV/AIDS (UNAIDS), has also flagged in the past that the drug is unaffordable for many people in Africa, where the medicine has the potential to have the biggest impact. Roughly two-thirds of the people living with HIV worldwide live in sub-Saharan Africa. Gilead said in a statement last year that it had been 'developing a strategy to enable broad, sustainable access globally' to lenacapavir, although the company has not yet provided detailed information on how it will do this. One option could be 'voluntary licensing,' where other companies are granted permission to produce and sell generic versions of a patented product exclusively to people in certain (often low-income) countries. Researchers at the University of Liverpool in the UK have calculated that a year's worth of lenacapavir could be made available for as little as $25. This story originally appeared on WIRED en Español and has been translated from Spanish.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
111: Q1 Earnings Snapshot
SHANGHAI (AP) — SHANGHAI (AP) — 111 Inc. (YI) on Thursday reported a loss of $2.4 million in its first quarter. The Shanghai-based company said it had a loss of 20 cents per share. The Operator of a digital and mobile healthcare platform in China posted revenue of $486.3 million in the period. _____
